All lobbying firms
Gilead Sciences, Inc.
Gilead Sciences, Inc. has made 7 Lobbying Disclosure Act filings for 1 client since 2025, reporting $14,942,000 of in-house lobbying expenses; the newest was posted October 21, 2026.
$0
Income reported
1
Clients represented
7
Filings counted
0
Former members lobbying
Clients
1
- Gilead Sciences Inc. $14,942,000
Lobbyists named
1
- RILEY SWINEHART
Reported by year
2 years
- 2026 $7,100,000
- 2025 $7,842,000
Issues lobbied
6
Agencies and chambers lobbied
17
- Centers For Disease Control & Prevention (CDC)
- Centers For Medicare and Medicaid Services (CMS)
- Commerce, Dept of (DOC)
- Food & Drug Administration (FDA)
- Health & Human Services, Dept of (HHS)
- HOUSE OF REPRESENTATIVES
- Natl Institutes of Health (NIH)
- Patent & Trademark Office (PTO)
- SENATE
- State, Dept of (DOS)
- Treasury, Dept of
- U.S. Trade Representative (USTR)
- White House Office
- Office of Management & Budget (OMB)
- Executive Office of the President (EOP)
- Office of Science & Technology Policy (OSTP)
- Office of the Vice President of the United States
Recent filings
8 total
Q3 amendment
View →
Q3 report
View →
Q2 report
View →
Q1 report
View →
Q4 report
View →
Q3 report
View →
Q2 report
View →
Q1 report
View →
Gilead Sciences Inc.
Gilead Sciences Inc.
Amended
Gilead Sciences Inc.
Gilead Sciences Inc.
Gilead Sciences Inc.
Gilead Sciences Inc.
Gilead Sciences Inc.
Gilead Sciences Inc.